A news report from China.org.cn on Myanmar earthquake and China's rescue efforts:   "Don't be afraid! We've come to your rescue!" The words, shouted in Mandarin with a Guizhou accent and translated ...

Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that ...

Quantum BioPharma (NASDAQ: QNTM) a biopharmaceutical company advancing innovative biotech assets, announced a joint clinical study with Massachusett ...

It’s the nature of the beast,” says Lt. Andre LaFontaine, Emergency Medical Services coordinator for the Lowell Fire ...

Lucid Diagnostics (NASDAQ:LUCD – Get Free Report)‘s stock had its “overweight” rating reiterated by stock analysts at Cantor ...

Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced a ...

On Wednesday, firefighters with the Raleigh Fire Department were offered screenings for esophageal precancer through a new ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Quince Therapeutics (QNCX – Research Report), ...

Discover PAVmed Inc.'s Q4 2024 earnings highlights, including Lucid Diagnostics' 45% test growth, Veris Health advancements, and strategic milestones.

Lucid processed record test volume, saw rapid initial uptake in concierge medicine contracts, and secured first commercial insurance coverage policies Veris Health ...

Q4 2024 Earnings Call Transcript March 24, 2025 Lucid Diagnostics Inc. misses on earnings expectations. Reported EPS is ...